Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Cannabis Regulation topic
No spam. Unsubscribe anytime.
Committee weighs tighter rules for hemp‑derived THC products and 21+ sales limit
Summary
Deputy Chief Danielle Ellison and public‑health advocates told the committee that federal farm‑bill changes and mislabeled products let high‑THC hemp items reach retail; SB 624 would redefine hemp product limits, create age restrictions and point liquor‑licensed retailers to enforcement rules the commission would set.
Senators opened a public hearing on SB 624, legislation intended to close gaps that allowed hemp‑derived products containing intoxicating levels of THC isomers to enter New Hampshire retail channels.
Danielle Ellison of New Hampshire Liquor Enforcement described the federal farm‑bill loophole that, she said, created a product market for edible and drinkable hemp derivatives not originally intended by the law. Ellison said enforcement has been hampered by inconsistent definitions and missing labeling/testing requirements, and she described reported incidents of children as young as 12 purchasing high‑THC hemp products.
The amendment described to the committee mirrors recent federal containerization and potency rules (a 3 percent dry‑weight cap and a 4‑milligram total per container provision in the amendment as drafted) and would create a baseline 21‑and‑older sales restriction for licensed outlets. Witnesses from public‑health and prevention organizations supported the measure as a youth‑protection tool; industry representatives cautiously supported the age restriction and urged careful drafting to avoid unintended personal‑possession criminal penalties.
Committee questions focused on the effective date (noted at the hearing as 01/01/2027 in one exchange), how administrative penalties would be created through rulemaking rather than written directly into the statute, and whether chemical forms such as THCA were consistently captured in the amendment language. Several public witnesses asked the committee to make the statutory language consistent across lines so THCA and other tetrahydrocannabinoids are unambiguously included.
The item remained at the hearing stage while senators and witnesses discussed a forthcoming amendment (O483) to be circulated and reviewed.
